JULIE ALVARADO: Open Payments
NPI 1003215260 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 26 payments from 13 companies in 2025. Trend: 2023 $1,300 · 2024 $1,136 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $80 |
| Amgen Inc. | 4 | $69 |
| Novo Nordisk Inc | 3 | $58 |
| Aimmune Therapeutics, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Boston Scientific Corporation | 1 | $17 |
Products named: VRAYLAR, Rybelsus, OTEZLA, REXULTI, ZENPEP, The Cologuard Plus Collection Kit, Auvelity, JARDIANCE.
Industry payments across MI — which companies pay providers there.
